Physical Activity, Weight, and Outcomes in Patients Receiving Chemotherapy for Metastatic Breast Cancer (C40502/Alliance)Jennifer A. Ligibel, Eric P. Winer, Luke Huebner et al.|JNCI Cancer Spectrum|2021Cited by 16
Abstract P1-05-20: Validation of the HER2 Activation Response Predictive Signature (HARPS) as a Predictive Biomarker for HER2+ Therapy Response in the Neoadjuvant SettingEmanuel Petricoin, Shridar Ganesan, Coral Omene et al.|Clinical Cancer Research|2025Cited by 0